Axios Harris Poll 100: Pfizer, Moderna reputations soar post-vaccine
America's affections have shifted away from the companies that helped us manage pandemic life and toward the vaccine manufacturers that are helping to end it.
Driving the news: Moderna and Pfizer shot up the ranks this year in the Axios/Harris 100, our annual survey of corporate reputations. Moderna is Americans' third-favorite company this year, and Pfizer came in at seventh — up from No. 61 a year ago.
- CVS climbed 13 spots since last year.
- Yes, but: Johnson & Johnson isn’t getting the same bounce from its coronavirus vaccine. It fell four spots, slipping to No. 72 on this year's list — considered a "good" but not "excellent" or "very good" corporate reputation.
Flashback: A year ago, when Americans were still sanitizing our groceries and figuring out how to live in a state of lockdown, Clorox was America's favorite company. Instacart, Peloton and Zoom leapt onto the list for the first time in 2020.
- None of those companies made the cut this year.